Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
7.13M
-
Shares change
-
+86.9K
-
Total reported value, excl. options
-
$76.9M
-
Value change
-
+$1M
-
Number of buys
-
15
-
Number of sells
-
-20
-
Price
-
$10.79
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q4 2020
48 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q4 2020.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.13M shares
of 13.8M outstanding shares and own 51.53% of the company stock.
Largest 10 shareholders include Battery Management Corp. (2.42M shares), NEA Management Company, LLC (1.71M shares), BlackRock Inc. (465K shares), VANGUARD GROUP INC (432K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (252K shares), RENAISSANCE TECHNOLOGIES LLC (222K shares), Roubaix Capital, LLC (207K shares), Millrace Asset Group, Inc. (182K shares), DIMENSIONAL FUND ADVISORS LP (132K shares), and NORTHERN TRUST CORP (107K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.